Roche has released an app called AsthmApp for their ACOUSTICS trial.
The study is for adolescents with uncontrolled asthma who are failing with standard of care therapy. Roche is studying an immunomodulator in this patient group.
What’s interesting about the AsthmApp is it’s not aimed at the study participants, but the parents and care providers.
This is another example of a clinical trial being performed with adjunct apps to support patient compliance — recently Children’s Hospital Los Angeles launched their own app for a large study being performed on sickle cell disease patients.
I do wonder how researchers will take into account the usage of the apps in the results. For example, did the study participant improve because of the drug or did they improve because their parents had an app that helped them better manage their child’s asthma?